In Vitro Diagnostics Technology and Industry Development Summit 2011

Organized by eChinaChem, Inc., Shanghai Licensed Pharmacist Association, The Shanghai Medical Instrument Trade Association, Research Center of Econometrics, Shanghai Academy of Social Sciences, In Vitro Diagnostics Technology and Industry Development Summit every year since 2011. For more information about the organizers, please refer to Organizers.

IVD development is at the frontier of medical services and research, and is a key area in preventive medicine R&D. Innovations and advancement in various IVD technologies have led to the development of new diagnostics test applications, resulting in a phenomenal growth of the IVD market. The IVD market of China, averaging double-digit growth annually in the past decade, has fostered competition amongst IVD firms in recent years, thus accelerating development of new technologies and products.

The global IVD market totaled $34 billion in 2007 and $38 billion for 2008. Despite the 2009 global economic crisis, the conditions of the traditional IVD market has not changed and it is expected to generate an annualized 9% growth rate from 2010 to 2012 according to market analysts.

At present, China is still one of the lowest IVD consumption per capita countries, with about 1/5 of the population of the world and only 2% of the global IVD industry market share. Yet China is the fastest growing market, with an average annual growth rate of 15%.

This Summit will discuss commercial and regulatory challenges in China, the recent development of diagnostic reagents in the biopharmaceutical industry, emerging technologies in diagnostics and other development for IVD, and will offer an opportunity for persons interested in every aspect of IVD to become familiar with cutting-edge developments and their potential application in IVD arenas.